Discussions Around the DeLLphi-305 Trial
Sep 10, 2026
View online
Discussions Around the DeLLphi-305 Trial
Sevabertinib Moves Into First-Line HER2-Mutant NSCLC With FDA Accelerated Approval
FDA Expands Accelerated Approval of Sevabertinib for HER2-Mutant Non-small Cell Lung Cancer
David Tuveson Appointed Executive Director of Duke Cancer Institute
Dana-Farber Launches Solavia Decision Suite to Bring Cancer Treatment Expertise Into Clinical Workflow
Antoni Ribas Receives 2026 ESMO Lifetime Achievement Award
Agenus to Present 3-Year Overall Survival Data for BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026
Building on VIRO 2025, AVEO Oncology Continues Partnership as Bronze Sponsor of VIRO 2026
NIH Academic–Industrial Partnerships for Translation of Technologies R01 Grant 2026
NCI Pathway to Independence K99/R00 Award 2026
One Retinoblastoma World 2026
World Conference on Lung Cancer 2026
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
